Background and activities

Cathrine Broberg Vågbø has a PhD in molecular medicine and is affiliated at the Proteomics and Modomics Experimental Core facility (PROMEC), Department of Clinical and Molecular Medicine, NTNU. Specialized in RNA epitranscriptomics and DNA epigenetics that regulate gene expression and thus almost all aspects of cell biology. The primary research focus is to understand how errors that occur in these systems lead to the development of human disease. Mass spectrometry-based methods are central for the characterization of the regulatory RNA and DNA modifications, methods that are currently part of the analytical repertoire of the PROMEC core facility and used by a number of research groups nationally and internationally.

Publications

Published 37 articles (PubMed) in peer-reviewed international journals. Currently > 4000 citations and an h-index of 23 (ResearcherID).

Statistics: Journal (impact factor, number of publications): Nature (43.1, 2), Cell (38.6, 1), Nat Neurosci (21.1, 1), Mol Cell (14.5, 2), Sci Adv (13.1, 1), Genes&Dev (12.6, 2), Nat Commun (11.9, 2), EMBO J (11.2, 2), Nucleic Acids Res (11.1, 6), J Cell Biol  (9.6, 1), Am J Hum Genet (9.0, 1), Cell Rep (8.7, 2), Oncotarget (6.0, 1), J Transl Med (5.5, 1), Epigenet Chromatin (5.2, 1), DNA Rep (4.9, 5), J Biol Chem (4.6, 1), Cell Discov (4.5, 1), Sci Rep (4.5, 1), Mol Cell Biol (4.4, 1), PlosOne (3.5, 1), J Pharmacol Exp Ther (3.0, 1), F1000Res (1.7, 1), J Clin Pharm (1.7, 1).

Authored textbook chapter: Genomic Uracil: Evolution, Biology, Immunology and Disease, ISBN 9813233494, World Scientific publishing (2018).

Scientific, academic and artistic work

A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database

2021

2020

2019

2017

2016

2015